• Markets
  • icon
  • Companies
OPT · ASX

Opthea Limited (ASX:OPT)

AU$0.5

 0.0 (0.0%)
ASX:Live
05/12/2023 04:10:44 PM
Recent Earnings downgrade HALO Price Momentum HALO Ords HALO Momentum HALO Consensus Value +5
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

OPT Overview

OPT Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About OPT

Telephone

Address

Description

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.

OPT Price Chart

Key Stats

Market Cap

AU$324.78M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.31 - 0.97

Trade Value (12mth)

AU$67,296.00

1 week

20.24%

1 month

46.38%

YTD

-40.81%

1 year

-44.2%

All time high

3.91208

Key Fundamentals

EPS 3 yr Growth

611.700%

EBITDA Margin

%

Operating Cashflow

-$179m

Free Cash Flow Return

-586.90%

ROIC

-693.50%

Interest Coverage

-11.20

Quick Ratio

5.20

Other Data

Shares on Issue (Fully Dilluted)

496m

HALO Sector

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.22

OPT Announcements

Latest Announcements

Date Announcements

31 October 23

Opthea to present at Eyecelerator at AAO

×

Opthea to present at Eyecelerator at AAO

31 March 22

Change in substantial holding

×

Change in substantial holding

31 January 23

Opthea to Present at Sequire Biotechnology Conference

×

Opthea to Present at Sequire Biotechnology Conference

31 January 22

Becoming a substantial holder

×

Becoming a substantial holder

31 January 08

Circadian Technologies - Corporate Presentation

×

Circadian Technologies - Corporate Presentation

31 January 08

Circadian Technologies - Corporate Presentation (amended)

×

Circadian Technologies - Corporate Presentation (amended)

31 August 23

Opthea Retail Entitlement Offer Opens

×

Opthea Retail Entitlement Offer Opens

31 August 23

Preliminary Final Report

×

Preliminary Final Report

30 September 22

Application for quotation of securities - OPT

×

Application for quotation of securities - OPT

30 September 15

Circadian Technologies Limited - Annual Report 2015 (CIR-AU)

×

Circadian Technologies Limited - Annual Report 2015 (CIR-AU)

30 September 14

Circadian Technologies Limited - Annual Report 2014 (CIR-AU)

×

Circadian Technologies Limited - Annual Report 2014 (CIR-AU)

30 October 15

Circadian Technologies Limited - Notice of Annual General Meeting and Proxy Form (CIR-AU)

×

Circadian Technologies Limited - Notice of Annual General Meeting and Proxy Form (CIR-AU)

30 November 23

2023 AGM Chairmans Address

×

2023 AGM Chairmans Address

30 November 23

Results of Meeting

×

Results of Meeting

30 November 22

Appendix 2A

×

Appendix 2A

30 November 22

Cleansing Notice

×

Cleansing Notice

30 November 15

Circadian Technologies Limited - Chairman's address to the Annual General Meeting (CIR-AU)

×

Circadian Technologies Limited - Chairman's address to the Annual General Meeting (CIR-AU)

30 November 15

Circadian Technologies Limited - CEO Presentation for the Annual General Meeting (CIR-AU)

×

Circadian Technologies Limited - CEO Presentation for the Annual General Meeting (CIR-AU)

30 November 15

Circadian Technologies Limited - Results of the Annual General Meeting (CIR-AU)

×

Circadian Technologies Limited - Results of the Annual General Meeting (CIR-AU)

30 March 22

Change in substantial holding

×

Change in substantial holding

30 August 22

Opthea Appendix 4E and Annual Report 2022

×

Opthea Appendix 4E and Annual Report 2022

30 August 22

Opthea reports Fiscal Year 2022 Results and Highlights

×

Opthea reports Fiscal Year 2022 Results and Highlights

30 August 22

Opthea Appendix 4G Corporate Governance Statement 2022

×

Opthea Appendix 4G Corporate Governance Statement 2022

30 August 21

Opthea Appendix 4E and Annual Report

×

Opthea Appendix 4E and Annual Report

30 August 17

Opthea Appendix 4E and Annual Report 2017

×

Opthea Appendix 4E and Annual Report 2017

30 April 07

To present at US Investor Forums

×

To present at US Investor Forums

29 October 18

Notice of Annual General Meeting and Proxy Form

×

Notice of Annual General Meeting and Proxy Form

OPT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.19 -0.36 -0.45 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.19 -0.36 -0.45 Lock Lock Lock
     Growth % Lock Lock Lock Lock -199.2 -91.9 -23.9 Lock Lock Lock
     PE X Lock Lock Lock Lock 953.6 N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 3.1 N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.11 -0.34 -0.40 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.19 -0.28 -0.38 Lock Lock Lock
     Growth % Lock Lock Lock Lock -243.8 -199.6 -19.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -14.3 -25.4 -73.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.51 0.20 -0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.51 0.20 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 113.2 -61.4 -109.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 320 352 470 Lock Lock Lock
Basic m Lock Lock Lock Lock 320 352 470 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5.6 35.9 28.9 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 53 133 223 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -53 -133 -223 Lock Lock Lock
     Growth % Lock Lock Lock Lock -109.6 -151.1 -67.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -57,660.0 -106,489.5 -138,554.5 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -53 -133 -223 Lock Lock Lock
     Growth % Lock Lock Lock Lock -109.0 -150.6 -67.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -57,815.4 -106,576.0 -138,647.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -67 -137 -221 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -7 -9 -9 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -61 -128 -212 Lock Lock Lock
     Growth % Lock Lock Lock Lock -267.8 -110.6 -65.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -66,087.3 -102,353.7 -131,469.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -61 -98 -179 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 157 0 249 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -61 -98 -179 Lock Lock Lock
     Growth % Lock Lock Lock Lock -594.9 -61.1 -82.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -664.0 -786.8 -1,112.8 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 157 65 134 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 184 87 148 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -157 -65 -134 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 18 157 Lock Lock Lock
Equity $m Lock Lock Lock Lock 180 70 -9 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 180 70 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 177.5 -61.3 -112.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.0 -146.6 -143.0 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.7 -183.4 2,409.6 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -43.3 -106.6 -729.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -49.6 -102.4 -693.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -49.8 -78.7 -586.9 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -11.2 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.0 0.5 0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -87.3 -93.0 1,520.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 44.5 5.0 5.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 44.5 5.0 5.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 85.6 74.5 90.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -1,475.6 -561.7 -636.8 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 3,501.1 13,260.1 16,632.4 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -73,285.4 -109,300.2 -136,936.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -36.6 -156.5 -148.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.0 -146.6 -143.0 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.0 1.3 -16.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.7 -183.4 2,409.6 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -33.7 -183.4 2,409.6 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 32,131.2 24,682.5 21,962.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 32,131.2 24,682.5 21,962.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 32,131.2 24,682.5 21,962.4 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.22%

Value ($M)

1

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

-0.40%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

OPT Shortsell

Frequently Asked Questions

The current share price of Opthea Limited (OPT:ASX) is AU$0.5.
The 52-week high share price for Opthea Limited (OPT:ASX) is AU$0.97.
The 52-week low share price for Opthea Limited (OPT:ASX)? is AU$0.31.
Opthea Limited (OPT:ASX) does not pay a dividend.
The last dividend payment of Opthea Limited (OPT:ASX) is AU$1.15.
Opthea Limited (OPT:ASX) has a franking level of 0%.
Opthea Limited (OPT:ASX) is classified in the Healthcare.
The current P/E ratio for Opthea Limited (OPT:ASX) is .